Sotera Health Q2 net income rises to $54 million; net revenues increase 9.2% to $321.38 million vs Q2 2025 - SHC News | RalliesSotera Health Q2 net income rises to $54 million; net revenues increase 9.2% to $321.38 million vs Q2 2025
S
SHC• Updated full-year outlook
- Full-year net revenues outlook raised to USD 1.236 billion-USD 1.254 billion.
- Adjusted EPS (non-GAAP) forecast lifted to USD 0.95-USD 1.01.
Quarterly results and segment revenue
- Sotera Health Q2 net revenues rose 9.2% to USD 321.38 million from a year earlier.
- Net income swung to USD 54 million, or USD 0.19 per diluted share.
- Adjusted EBITDA (non-GAAP) increased 10% to USD 165.74 million, lifting margin 0.4 percentage points to 51.6%.
- Segment net revenues climbed to USD 211.57 million at Sterigenics, USD 49.15 million at Nordion, and USD 60.66 million at Nelson Labs.
NVMI
•
